(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MORPHYLANE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MORPHYLANE

ST13

US500000079250393

Class

1, 9

Filing

79250393

Registration

6060919

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

05/27/2025

Trademark type

Combined

Nice classes

1, 9

Filing date

12/06/2018

Registration date

05/26/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/26/2020

Last transaction

05/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

DE

Examiner

VO, JULIE

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

thyssenkrupp AG
ThyssenKrupp Industrial Solutions AG
thyssenkrupp Uhde GmbH

Representatives

William J. Cassin thyssenkrupp North America, Inc. IP Serv

Technical classification

Nice Classes

Class 1Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Solvents for aromatic extractive distillation for industrial and commercial use

Class 9

Chemical and physical apparatus for the production of pure organochemical combinations for scientific industrial purposesnamely distillation and extractive distillation with counter-flow apparatus being columns equipped with packings and traysheat exchangerscontrol and regulation instrumentscontrol valves for pressuretemperaturelevel and flow of gases and liquids

Publications

History of USPTO decisions and trademark events.

33 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/26/2025

CHLD

CHANGE OF OWNER RECEIVED FROM IB

08/11/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/14/2020

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

09/25/2020

XXCR

GENERIC MADRID TRANSACTION CREATED

09/25/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/26/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

05/26/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/10/2020

PUBO

PUBLISHED FOR OPPOSITION

03/10/2020

GPNX

NOTIFICATION PROCESSED BY IB

03/06/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/19/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/19/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/19/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/30/2020

RNWL

INTERNATIONAL REGISTRATION RENEWED

10/31/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/11/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/10/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/10/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/26/2019

GNFR

FINAL REFUSAL E-MAILED

07/26/2019

CNFR

FINAL REFUSAL WRITTEN

07/26/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/19/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/19/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/19/2019

RFNT

REFUSAL PROCESSED BY IB

04/12/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/26/2019

RFRR

REFUSAL PROCESSED BY MPU

03/26/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/14/2019

CNRT

NON-FINAL ACTION WRITTEN

03/13/2019

DOCK

ASSIGNED TO EXAMINER

03/06/2019

MAFR

APPLICATION FILING RECEIPT MAILED

02/02/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/29/2019

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

01/24/2019

Continuous trademark protection

Get notified about every new filing that threatens MORPHYLANE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.